The Valley Desk

ArticleCancer medicinePublished

Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Cancer medicine
Published
Subject terms
Humans; Head and Neck Neoplasms; Cytokines; Neoadjuvant Therapy; Retrospective Studies; Aged; Middle Aged; Female; Male; Squamous Cell Carcinoma of Head and Neck; Nivolumab; Immune Checkpoint Inhibitors
PubMed ID
38847087
PubMed Central ID
PMC11157197
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal